Industry

DUBLIN–(BUSINESS WIRE)–The “Lutetium-177 (Lu-177) Global Market and Pipeline Analysis – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. Lutetium-177 (Lu-177) Global Market and Pipeline Analysis – Forecast to 2028″ gives comprehensive insights on the various Lu-177 based drugs being developed for the treatment of prostate cancer, NETs, Lung cancer, solid tumors and other … [Read more…]

— Data being presented at the European Academy of Neurology Congress demonstrates consistent reductions in NMOSD attacks and disability scores across populations — DUBLIN–(BUSINESS WIRE)–Horizon Therapeutics plc (Nasdaq: HZNP) today announced new findings from a post hoc analysis of the N-MOmentum Phase 3 pivotal trial of UPLIZNA supporting the medicine’s efficacy in Europeans living with … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Specialty Drug Distribution Market Research Report by Indication (AIDS, Hemophilia, and Multiple Sclerosis), Type, Distribution Type, Distribution Channel, State – United States Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to ResearchAndMarkets.com’s offering. The United States Specialty Drug Distribution Market size was estimated at USD 340.41 million in 2021 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Body Contouring Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” report has been added to ResearchAndMarkets.com’s offering. The global body contouring market reached a value of $7.3 Billion in 2021. Looking forward, the publisher expects the market to reach $11.1 Billion by 2027, exhibiting a CAGR of 6.9% during 2022-2027. … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Urethral Cancer Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. Scope The pipeline guide provides a snapshot of the global therapeutic landscape of Urethral Cancer The pipeline guide reviews pipeline therapeutics for Urethral Cancer by companies and universities/research institutes based on … [Read more…]

SEATTLE–(BUSINESS WIRE)–Kubota Vision Inc. (“Kubota Vision”), a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd. (Tokyo 4596), announced today the completion of the phase 3 clinical trial investigating emixustat hydrochloride (“emixustat”) in patients with macular atrophy secondary to Stargardt disease. The study was a multi-center, randomized, double-masked, and placebo-controlled phase 3 … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Geographic Atrophy Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information on the therapeutics under development for Geographic Atrophy, complete with analysis by Stage of Development, Drug Target, Mechanism of Action (MoA), Route of Administration (RoA) and … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) – Market Insight, Epidemiology and Market Forecast -2032” report has been added to ResearchAndMarkets.com’s offering. This report delivers an in-depth understanding of the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD), historical and forecasted epidemiology as well as the Systemic Sclerosis-associated Interstitial Lung Disease (SSc-ILD) market trends in the … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Global E-Pharmacy Market Size & Share to 2027” report has been added to ResearchAndMarkets.com’s offering. E-pharmacy is referred as electronic pharmacy or internet pharmacy. It is an online retail platform which acts as bridge between consumers and vendors to enable the sales of medicines. It provides round-the-clock delivery of drugs access to comprehensive … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Bone Growth Stimulators – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. The global market for Bone Growth Stimulators estimated at US$999.4 Million in the year 2020, is projected to reach a revised size of US$1.27 Billion by 2026, growing at a CAGR of 4.2% over the analysis period. … [Read more…]